HALO
#801
Halozyme Therapeutics, Inc. - Common Stock
110.2 8 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.57%
Variación mensual
+33.22%
Variación en los últimos 6 meses
+58.28%
Cambio anual
+65.09%
Cierres anteriores
109.6 6
Open
110.0 0
Mínimo
109.8 2
Máximo
110.4 1
Volumen
256
Financials
- Market Capitalization 12.52 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
22.89
Relación precio/flujo de caja
5.77
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 785 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.61 USD | -0.54% | +1.87% | +11.22% | +13.07% | 12.89 B USD | ||
| 798 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.72 USD | -0.59% | -0.24% | +10.35% | +28.35% | 12.56 B USD | ||
| 809 |  CORT Corcept Therapeutics Incorporated - Common Stock | 114.22 USD | +3.43% | -3.42% | +1.08% | +55.68% | 12.35 B USD | ||
| 821 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.30 USD | -0.08% | -3.62% | -2.20% | +118.16% | 12.05 B USD |